ALZpath

Carlsbad, United States Founded: 2020 • Age: 6 yrs
Diagnostic solutions for Alzheimers disease are developed using blood-based biomarkers.

About ALZpath

ALZpath is a company based in Carlsbad (United States) founded in 2020 by Eric Reiman, Venkat Shastri, and Jerre Stead.. The company has 6 employees as of December 31, 2022. ALZpath offers products and services including pTau217 Assay. ALZpath operates in a competitive market with competitors including Todos Medical, C₂N Diagnostics, ADmit Therapeutics, SYNAPS Dx and Amydis Diagnostics, among others.

  • Headquarter Carlsbad, United States
  • Employees 6 as on 31 Dec, 2022
  • Founders Eric Reiman, Venkat Shastri, Jerre Stead
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Alzpath Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    6

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ALZpath

ALZpath offers a comprehensive portfolio of products and services, including pTau217 Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Blood-based test for early detection of Alzheimer's disease markers.

Funding Insights of ALZpath

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2023 Amount Seed - ALZpath Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ALZpath

ALZpath has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alzheimer's Drug Discovery. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Drugs for Alzheimer's prevention, treatment, and cure are discovered.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ALZpath

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ALZpath

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Alzpath Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ALZpath

ALZpath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Todos Medical, C₂N Diagnostics, ADmit Therapeutics, SYNAPS Dx and Amydis Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Todos Medical is focused on developing diagnostic blood tests.
domain founded_year HQ Location
Diagnostics and therapies for Alzheimer's disease are developed.
domain founded_year HQ Location
Early Alzheimer's detection is facilitated through blood-based epigenetic diagnostics.
domain founded_year HQ Location
Developer of a diagnostic test to detect Alzheimer's disease
domain founded_year HQ Location
Developer of diagnostics test for detection of Alzheimer's disease
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about ALZpath

When was ALZpath founded?

ALZpath was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Where is ALZpath located?

ALZpath is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.

Who is the current CEO of ALZpath?

Venkat Shastri is the current CEO of ALZpath. They have also founded this company.

How many employees does ALZpath have?

As of Dec 31, 2022, the latest employee count at ALZpath is 6.

What does ALZpath do?

ALZpath was founded in 2020 and is based in Carlsbad, United States. Operations center on the biotechnology sector, with a focus on diagnostic tools for Alzheimers disease. A blood-based biomarker assay targeting phosphorylated tau 217 (ptau217) is provided by the company to detect the condition prior to symptom onset. Leadership includes co-founders Eric Reiman, Venkat Shastri as CEO, and Jerre Stead.

Who are the top competitors of ALZpath?

ALZpath's top competitors include ADmit Therapeutics, C₂N Diagnostics and Todos Medical.

What products or services does ALZpath offer?

ALZpath offers pTau217 Assay.

Who are ALZpath's investors?

ALZpath has 1 investor. Key investors include Alzheimer's Drug Discovery.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available